Lack of association of baseline 25-hydroxyvitamin D levels with disease severity and mortality in Indian patients hospitalized for COVID-19
Abstract Vitamin D deficiency (VDD) owing to its immunomodulatory effects is believed to influence outcomes in COVID-19. We conducted a prospective, observational study of patients, hospitalized with COVID-19. Serum 25-OHD level < 20 ng/mL was considered VDD. Patients were classified as having mi...
Enregistré dans:
Auteurs principaux: | Ganesh Jevalikar, Ambrish Mithal, Anshu Singh, Rutuja Sharma, Khalid J. Farooqui, Shama Mahendru, Arun Dewan, Sandeep Budhiraja |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/1476d0fbc9b54c9c9febad184eeb46a1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Low FT3 is an independent marker of disease severity in patients hospitalized for COVID-19
par: Aditya Dutta, et autres
Publié: (2021) -
Serum 25-hydroxyvitamin D predicts cognitive performance in adults
par: Darwish H, et autres
Publié: (2015) -
Comparison of Serum 25-Hydroxyvitamin D Levels in Children with and without Intussusception
par: MR Esmaeili Doki, et autres
Publié: (2020) -
Development and analytical validation of a novel bioavailable 25-hydroxyvitamin D assay.
par: Anders H Berg, et autres
Publié: (2021) -
Serum 25-hydroxyvitamin D concentration in Children with Lower Respiratory Tract Infection
par: Asmaa Salah Barania, et autres
Publié: (2020)